# Extension Study to PTR-01-002 (A Study in Recessive Dystrophic Epidermolysis Bullosa (RDEB) Patients Previously Treated With PTR-01)

> **NCT05143190** · PHASE2 · COMPLETED · sponsor: **Phoenix Tissue Repair, Inc.** · enrollment: 2 (actual)

## Conditions studied

- Recessive Dystrophic Epidermolysis Bullosa

## Interventions

- **DRUG:** PTR-01

## Key facts

- **NCT ID:** NCT05143190
- **Lead sponsor:** Phoenix Tissue Repair, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-02
- **Primary completion:** 2022-06-20
- **Final completion:** 2022-08-09
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2022-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05143190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05143190, "Extension Study to PTR-01-002 (A Study in Recessive Dystrophic Epidermolysis Bullosa (RDEB) Patients Previously Treated With PTR-01)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05143190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*